Transcriptional	O
analysis	O
of	O
Epstein-Barr	O
virus	O
gene	O
expression	O
in	O
EBV-positive	O
gastric	O
carcinoma	O
:	O
unique	O
viral	O
latency	O
in	O
the	O
tumour	B-cell_type
cells	I-cell_type
.	O

Although	O
case-oriented	O
evidence	O
for	O
an	O
association	O
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
with	O
gastric	O
carcinoma	O
has	O
been	O
accumulating	O
recently	O
,	O
the	O
interaction	O
(	O
s	O
)	O
between	O
EBV	O
and	O
gastric	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
is/are	O
largely	O
unknown	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
seven	O
EBV-positive	O
gastric	O
carcinoma	O
tissues	O
for	O
viral	O
gene	O
expression	O
at	O
the	O
mRNA	O
level	O
,	O
from	O
which	O
studies	O
on	O
the	O
EBV	O
oncogenicity	O
in	O
human	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
will	O
benefit	O
.	O

Reverse	O
transcription-PCR	O
analysis	O
showed	O
that	O
all	O
seven	O
EBV-positive	O
tumour	O
tissues	O
constitutively	O
expressed	O
EBV	B-RNA
nuclear	I-RNA
antigen	I-RNA
(	I-RNA
EBNA	I-RNA
)	I-RNA
1	I-RNA
mRNA	I-RNA
,	O
but	O
not	O
EBNA2	B-RNA
mRNA	I-RNA
.	O

The	O
EBNA	B-protein
transcription	O
was	O
initiated	O
from	O
one	O
of	O
three	O
EBNA	B-DNA
promoters	I-DNA
,	O
Qp	B-DNA
:	O
by	O
contrast	O
,	O
both	O
Cp	B-DNA
and	O
Wp	B-DNA
were	O
silent	O
,	O
thus	O
resulting	O
in	O
the	O
lack	O
of	O
EBNA2	B-RNA
mRNA	I-RNA
.	O

Latent	B-RNA
membrane	I-RNA
protein	I-RNA
(	I-RNA
LMP	I-RNA
)	I-RNA
2A	I-RNA
mRNA	I-RNA
was	O
detected	O
in	O
three	O
of	O
seven	O
cases	O
;	O
however	O
,	O
neither	B-RNA
LMP1	I-RNA
nor	I-RNA
LMP2B	I-RNA
mRNA	I-RNA
was	O
detected	O
in	O
any	O
of	O
the	O
tumours	O
tested	O
.	O

Transcripts	O
from	O
the	O
BamHI-A	B-DNA
region	I-DNA
of	O
the	O
viral	B-DNA
genome	I-DNA
were	O
detectable	O
in	O
all	O
cases	O
.	O

BZLF1	B-RNA
mRNA	I-RNA
and	O
the	O
product	O
,	O
an	O
immediate-early	B-DNA
gene	I-DNA
for	O
EBV	O
replication	O
,	O
was	O
not	O
expressed	O
in	O
any	O
of	O
them	O
,	O
thereby	O
suggesting	O
that	O
the	O
tumour	B-cell_type
cells	I-cell_type
carried	O
EBV	B-DNA
genomes	I-DNA
in	O
a	O
tightly	O
latent	O
form	O
.	O

These	O
findings	O
further	O
extended	O
our	O
previous	O
data	O
regarding	O
EBV	O
latency	O
in	O
gastric	B-cell_type
carcinoma	I-cell_type
cells	I-cell_type
at	O
the	O
protein	O
level	O
,	O
and	O
have	O
affirmed	O
that	O
the	O
programme	O
of	O
viral	O
gene	O
expression	O
in	O
the	O
tumour	O
more	O
closely	O
resembles	O
'latency	O
I	O
'	O
represented	O
by	O
Burkitt	O
's	O
lymphoma	O
than	O
'latency	O
II	O
'	O
represented	O
by	O
the	O
majority	O
of	O
nasopharyngeal	O
carcinomas	O
.	O

British	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1996	NULL
)	NULL
74	NULL
,	NULL
625-631	NULL
Â©	NULL
1996	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0007-0920/96	NULL
$	NULL
12.00	NULL
Transcriptional	NULL
analysis	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
gene	NULL
expression	NULL
in	NULL
EBV	NULL
positive	NULL
gastric	NULL
carcinoma	NULL
:	NULL
unique	NULL
viral	NULL
latency	NULL
in	NULL
the	NULL
tumour	NULL
cells	NULL
M	NULL
Sugiura	NULL
'	NULL
,	NULL
S	NULL
Imai	NULL
'	NULL
,	NULL
M	NULL
Tokunaga	NULL
``	NULL
,	NULL
S	NULL
Koizumi	NULL
'	NULL
,	NULL
M	NULL
Uchizawa	NULL
'	NULL
,	NULL
K	NULL
Okamoto*	NULL
and	NULL
T	NULL
Osato	NULL
'	NULL
'Department	NULL
of	NULL
Virology	NULL
,	NULL
Cancer	NULL
Institute	NULL
,	NULL
Hokkaido	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
N15	NULL
W7	NULL
,	NULL
Kita-ku	NULL
,	NULL
Sapporo	NULL
060	NULL
,	NULL
Japan	NULL
;	NULL
*Department	NULL
of	NULL
Pathology	NULL
,	NULL
Kagoshima	NULL
City	NULL
Hospital	NULL
,	NULL
Kajiya-cho	NULL
20-17	NULL
,	NULL
Kagoshima	NULL
892	NULL
,	NULL
Japan	NULL
;	NULL
Departments	NULL
of	NULL
*Internal	NULL
Medicine	NULL
and	NULL
``	NULL
Pathology	NULL
,	NULL
Kin-ikyo	NULL
Central	NULL
Hospital	NULL
,	NULL
Fushiko	NULL
10-2	NULL
,	NULL
Higashi-ku	NULL
,	NULL
Sapporo	NULL
065	NULL
,	NULL
Japan	NULL
.	NULL

Summary	NULL
Although	NULL
case-oriented	NULL
evidence	NULL
for	NULL
an	NULL
association	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
with	NULL
gastric	NULL
carcinoma	NULL
has	NULL
been	NULL
accumulating	NULL
recently	NULL
,	NULL
the	NULL
interaction	NULL
(	NULL
s	NULL
)	NULL
between	NULL
EBV	NULL
and	NULL
gastric	NULL
epithelial	NULL
cells	NULL
is/are	NULL
largely	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
seven	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
for	NULL
viral	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
,	NULL
from	NULL
which	NULL
studies	NULL
on	NULL
the	NULL
EBV	NULL
oncogenicity	NULL
in	NULL
human	NULL
epithelial	NULL
cells	NULL
will	NULL
benefit	NULL
.	NULL

Reverse	NULL
transcription-PCR	NULL
analysis	NULL
showed	NULL
that	NULL
all	NULL
seven	NULL
EBV-positive	NULL
tumour	NULL
tissues	NULL
constitutively	NULL
expressed	NULL
EBV	NULL
nuclear	NULL
antigen	NULL
(	NULL
EBNA	NULL
)	NULL
1	NULL
mRNA	NULL
,	NULL
but	NULL
not	NULL
EBNA2	NULL
mRNA	NULL
.	NULL

The	NULL
EBNA	NULL
transcription	NULL
was	NULL
initiated	NULL
from	NULL
one	NULL
of	NULL
three	NULL
EBNA	NULL
promoters	NULL
,	NULL
Qp	NULL
;	NULL
by	NULL
contrast	NULL
,	NULL
both	NULL
Cp	NULL
and	NULL
Wp	NULL
were	NULL
silent	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
the	NULL
lack	NULL
of	NULL
EBNA2	NULL
mRNA	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP	NULL
)	NULL
2A	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
three	NULL
of	NULL
seven	NULL
cases	NULL
;	NULL
however	NULL
,	NULL
neither	NULL
LMP	NULL
]	NULL
nor	NULL
LMP2B	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
any	NULL
of	NULL
the	NULL
tumours	NULL
tested	NULL
.	NULL

Transcripts	NULL
from	NULL
the	NULL
BamHI-A	NULL
region	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
were	NULL
detectable	NULL
in	NULL
all	NULL
cases	NULL
.	NULL

BZLFI	NULL
mRNA	NULL
and	NULL
the	NULL
product	NULL
,	NULL
an	NULL
immediate-early	NULL
gene	NULL
for	NULL
EBV	NULL
replication	NULL
,	NULL
was	NULL
not	NULL
expressed	NULL
in	NULL
any	NULL
of	NULL
them	NULL
,	NULL
thereby	NULL
suggesting	NULL
that	NULL
the	NULL
tumour	NULL
cells	NULL
carried	NULL
EBV	NULL
genomes	NULL
in	NULL
a	NULL
tightly	NULL
latent	NULL
form	NULL
.	NULL

These	NULL
findings	NULL
further	NULL
extended	NULL
our	NULL
previous	NULL
data	NULL
regarding	NULL
EBV	NULL
latency	NULL
in	NULL
gastric	NULL
carcinoma	NULL
cells	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
and	NULL
have	NULL
affirmed	NULL
that	NULL
the	NULL
programme	NULL
of	NULL
viral	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
tumour	NULL
more	NULL
closely	NULL
resembles	NULL
'latency	NULL
I	NULL
'	NULL
represented	NULL
by	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
than	NULL
'latency	NULL
II	NULL
represented	NULL
by	NULL
the	NULL
majority	NULL
of	NULL
nasopharyngeal	NULL
carcinomas	NULL
.	NULL

Keywords	NULL
:	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
gastric	NULL
carcinoma	NULL
;	NULL
Epstein-Barr	NULL
virus-specific	NULL
mRNA	NULL
;	NULL
reverse	NULL
transcription	NULL
(	NULL
RT	NULL
)	NULL
-polymerase	NULL
chain	NULL
reaction	NULL
analysis	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
ubiquitous	NULL
human	NULL
herpes	NULL
virus	NULL
,	NULL
closely	NULL
associated	NULL
with	NULL
the	NULL
genesis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
,	NULL
undifferentiated	NULL
nasopharyngeal	NULL
carcinoma	NULL
(	NULL
NPC	NULL
)	NULL
and	NULL
opportunistic	NULL
lymphomas	NULL
in	NULL
immunocompro-mised	NULL
hosts	NULL
(	NULL
Liebowitz	NULL
and	NULL
Kieff	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
demonstrated	NULL
that	NULL
EBV	NULL
is	NULL
also	NULL
implicated	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
(	NULL
Herbst	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Pallesen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
certain	NULL
T-cell	NULL
lymphomas	NULL
(	NULL
Harabuchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Korbjuhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
thymic	NULL
carcinoma	NULL
(	NULL
Leyvraz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Dimery	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Patton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

All	NULL
or	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
neoplastic	NULL
cells	NULL
of	NULL
the	NULL
tumours	NULL
harbour	NULL
EBV	NULL
DNA	NULL
and	NULL
express	NULL
virus-coded	NULL
latent	NULL
infection	NULL
(	NULL
immortalisation-associated	NULL
)	NULL
proteins	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
EBV-related	NULL
malignancies	NULL
have	NULL
been	NULL
precisely	NULL
analysed	NULL
for	NULL
viral	NULL
latent	NULL
gene	NULL
expression	NULL
and	NULL
show	NULL
characteristic	NULL
patterns	NULL
for	NULL
each	NULL
individual	NULL
tumour	NULL
(	NULL
Liebowitz	NULL
and	NULL
Kieff	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Over	NULL
ten	NULL
major	NULL
EBV	NULL
genes	NULL
are	NULL
known	NULL
to	NULL
be	NULL
potentially	NULL
transcribed	NULL
in	NULL
cells	NULL
latently	NULL
infected	NULL
with	NULL
the	NULL
virus	NULL
:	NULL
EBV	NULL
nuclear	NULL
antigens	NULL
(	NULL
EBNA	NULL
)	NULL
1	NULL
,	NULL
-2	NULL
,	NULL
-3A	NULL
,	NULL
-3B	NULL
,	NULL
-3C	NULL
and	NULL
leader	NULL
protein	NULL
(	NULL
LP	NULL
)	NULL
;	NULL
latent	NULL
membrane	NULL
proteins	NULL
(	NULL
LMP	NULL
)	NULL
1	NULL
,	NULL
-2A	NULL
,	NULL
and	NULL
2B	NULL
;	NULL
untranslated	NULL
EBV-encoded	NULL
small	NULL
RNAs	NULL
(	NULL
EBER	NULL
)	NULL
-1	NULL
and	NULL
-2	NULL
(	NULL
Liebowitz	NULL
and	NULL
Kieff	NULL
,	NULL
1993	NULL
)	NULL
;	NULL
and	NULL
a	NULL
recently	NULL
found	NULL
transcript	NULL
containing	NULL
the	NULL
BamHI-A	NULL
rightward	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
BARFO	NULL
)	NULL
(	NULL
Gilligan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

All	NULL
the	NULL
latent	NULL
transcripts	NULL
are	NULL
regularly	NULL
expressed	NULL
in	NULL
in	NULL
vitro	NULL
EBV-immortalised	NULL
B-lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCL	NULL
)	NULL
and	NULL
some	NULL
B	NULL
lymphoproliferative	NULL
disorders	NULL
occurring	NULL
in	NULL
immunosuppressed	NULL
patients	NULL
(	NULL
latency	NULL
III	NULL
)	NULL
(	NULL
Young	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
EBERs	NULL
,	NULL
EBNA1	NULL
and	NULL
BamHI-A	NULL
transcripts	NULL
are	NULL
expressed	NULL
in	NULL
most	NULL
in	NULL
vivo	NULL
BL	NULL
cells	NULL
and	NULL
several	NULL
BL	NULL
cell	NULL
lines	NULL
(	NULL
latency	NULL
I	NULL
)	NULL
,	NULL
which	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
group	NULL
I	NULL
BL	NULL
cells	NULL
(	NULL
Rowe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Brooks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
;	NULL
and	NULL
three	NULL
LMP	NULL
genes	NULL
are	NULL
additionally	NULL
expressed	NULL
along	NULL
with	NULL
EBERs	NULL
,	NULL
EBNAL	NULL
and	NULL
BamHI-A	NULL
RNAs	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
NPC	NULL
and	NULL
HD	NULL
(	NULL
latency	NULL
II	NULL
)	NULL
cases	NULL
(	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Deacon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Correspondence	NULL
:	NULL
S	NULL
Imai	NULL
Received	NULL
21	NULL
September	NULL
1995	NULL
;	NULL
revised	NULL
6	NULL
February	NULL
1996	NULL
;	NULL
accepted	NULL
13	NULL
March	NULL
1996	NULL
Furthermore	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
EBNA	NULL
mRNA	NULL
expressed	NULL
depends	NULL
on	NULL
which	NULL
of	NULL
three	NULL
mutually	NULL
exclusive	NULL
EBNA	NULL
promoters	NULL
,	NULL
BamHI-C	NULL
,	NULL
-W	NULL
and	NULL
-Q	NULL
promoters	NULL
(	NULL
Cp	NULL
,	NULL
Wp	NULL
and	NULL
Qp	NULL
respectively	NULL
)	NULL
,	NULL
is	NULL
active	NULL
.	NULL

The	NULL
Cp-	NULL
or	NULL
Wp-initiated	NULL
large	NULL
primary	NULL
transcript	NULL
is	NULL
differentially	NULL
spliced	NULL
into	NULL
all	NULL
six	NULL
EBNA	NULL
mRNAs	NULL
as	NULL
is	NULL
seen	NULL
in	NULL
cells	NULL
with	NULL
latency	NULL
III	NULL
(	NULL
e.g	NULL
LCL	NULL
)	NULL
(	NULL
Rogers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
whereas	NULL
Qp	NULL
mediates	NULL
the	NULL
selective	NULL
expression	NULL
of	NULL
only	NULL
EBNA1	NULL
mRNA	NULL
through	NULL
bypassing	NULL
coding	NULL
regions	NULL
of	NULL
the	NULL
other	NULL
EBNA	NULL
genes	NULL
,	NULL
consequently	NULL
leading	NULL
to	NULL
the	NULL
complete	NULL
lack	NULL
of	NULL
EBNA2	NULL
,	NULL
-3A	NULL
,	NULL
-3B	NULL
,	NULL
-3C	NULL
and	NULL
-LP	NULL
mRNAs	NULL
represented	NULL
by	NULL
group	NULL
I	NULL
BL	NULL
and	NULL
NPC	NULL
cells	NULL
(	NULL
Schaefer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
19954	NULL
;	NULL
Nonkwelo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Gastric	NULL
carcinoma	NULL
,	NULL
the	NULL
most	NULL
common	NULL
malignancy	NULL
in	NULL
Japan	NULL
,	NULL
is	NULL
being	NULL
recognised	NULL
as	NULL
one	NULL
of	NULL
the	NULL
EBV-related	NULL
tumours	NULL
(	NULL
Shibata	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
previous	NULL
work	NULL
revealed	NULL
that	NULL
about	NULL
7	NULL
%	NULL
of	NULL
Japanese	NULL
gastric	NULL
carcinomas	NULL
were	NULL
EBV	NULL
genome-positive	NULL
and	NULL
that	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
EBERs	NULL
,	NULL
EBNA1	NULL
,	NULL
but	NULL
not	NULL
the	NULL
other	NULL
EBNAs	NULL
or	NULL
LMP1	NULL
,	NULL
protein	NULL
was	NULL
expressed	NULL
in	NULL
the	NULL
tumour	NULL
cells	NULL
(	NULL
Imai	NULL
et	NULL
aZ	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
details	NULL
about	NULL
expression	NULL
of	NULL
the	NULL
other	NULL
latent	NULL
genes	NULL
,	NULL
LMP2A	NULL
,	NULL
-2B	NULL
and	NULL
BARFO	NULL
,	NULL
and	NULL
about	NULL
utilisation	NULL
of	NULL
an	NULL
EBNA	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
also	NULL
necessary	NULL
to	NULL
understand	NULL
the	NULL
EBV-induced	NULL
oncogenic	NULL
process	NULL
,	NULL
are	NULL
still	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
analysed	NULL
seven	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
more	NULL
extensively	NULL
for	NULL
virus	NULL
latent	NULL
and	NULL
replication	NULL
cycle	NULL
gene	NULL
expression	NULL
together	NULL
with	NULL
EBNA	NULL
promoter	NULL
usage	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
,	NULL
using	NULL
the	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
technique	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Subjects	NULL
Tumour	NULL
tissues	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
resected	NULL
or	NULL
endoscopically	NULL
biopsied	NULL
from	NULL
the	NULL
stomachs	NULL
of	NULL
seven	NULL
patients	NULL
with	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
and	NULL
six	NULL
patients	NULL
with	NULL
EBV-negative	NULL
gastric	NULL
carcinoma	NULL
.	NULL

The	NULL
clinical	NULL
and	NULL
histological	NULL
data	NULL
of	NULL
the	NULL
patients	NULL
with	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
six	NULL
EBV-negative	NULL
tumours	NULL
consisted	NULL
of	NULL
two	NULL
well	NULL
differentiated	NULL
,	NULL
two	NULL
moderately	NULL
differentiated	NULL
and	NULL
two	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
626	NULL
poorly	NULL
differentiated	NULL
histological	NULL
types	NULL
.	NULL

EBV	NULL
positivity	NULL
of	NULL
the	NULL
cases	NULL
was	NULL
screened	NULL
by	NULL
the	NULL
PCR	NULL
assay	NULL
for	NULL
EBV	NULL
DNA	NULL
and	NULL
in	NULL
situ	NULL
hybridisation	NULL
for	NULL
EBER1	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

All	NULL
tumour	NULL
specimens	NULL
were	NULL
snap	NULL
frozen	NULL
and	NULL
stored	NULL
at	NULL
-80Â°C	NULL
until	NULL
use	NULL
.	NULL

They	NULL
were	NULL
obtained	NULL
after	NULL
informed	NULL
consent	NULL
of	NULL
the	NULL
patients	NULL
and	NULL
used	NULL
according	NULL
to	NULL
the	NULL
guidelines	NULL
of	NULL
the	NULL
Committee	NULL
for	NULL
Experimentation	NULL
and	NULL
Protection	NULL
of	NULL
Human	NULL
Subjects	NULL
,	NULL
Cancer	NULL
Institute	NULL
,	NULL
Hokkaido	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
.	NULL

Cell	NULL
lines	NULL
All	NULL
cell	NULL
lines	NULL
used	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
exponential	NULL
growth	NULL
phase	NULL
in	NULL
RPMI-1640	NULL
culture	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

An	NULL
EBV-transformed	NULL
LCL	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
detection	NULL
of	NULL
EBNA1I	NULL
,	NULL
-2	NULL
,	NULL
LMP1	NULL
,	NULL
-2A	NULL
,	NULL
-2B	NULL
mRNAs	NULL
;	NULL
Cp-	NULL
and	NULL
Wp-initiated	NULL
EBNA	NULL
mRNAs	NULL
;	NULL
and	NULL
BamHI-A	NULL
transcripts	NULL
.	NULL

A	NULL
group	NULL
I	NULL
BL	NULL
cell	NULL
line	NULL
,	NULL
Akata	NULL
(	NULL
Takada	NULL
and	NULL
Ono	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
Qp-initiated	NULL
EBNA	NULL
mRNA	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
the	NULL
EBV	NULL
replication-associated	NULL
BZLF	NULL
!	NULL

gene	NULL
mRNA	NULL
(	NULL
Countryman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
,	NULL
B95-8	NULL
cells	NULL
(	NULL
Miller	NULL
and	NULL
Lipman	NULL
,	NULL
1973	NULL
)	NULL
or	NULL
Akata	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
the	NULL
virus	NULL
replication	NULL
cycle	NULL
was	NULL
induced	NULL
by	NULL
cross-linking	NULL
of	NULL
the	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
G	NULL
by	NULL
treatment	NULL
with	NULL
goat	NULL
antibodies	NULL
to	NULL
human	NULL
IgG	NULL
(	NULL
Cappel	NULL
Research	NULL
Products	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
,	NULL
USA	NULL
)	NULL
(	NULL
Takada	NULL
and	NULL
Ono	NULL
,	NULL
1989	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

A	NULL
B-lymphoma	NULL
cell	NULL
line	NULL
,	NULL
BJAB	NULL
,	NULL
was	NULL
used	NULL
as	NULL
an	NULL
EBV-negative	NULL
control	NULL
(	NULL
Klein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1975	NULL
)	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
cDNA	NULL
synthesis	NULL
RNA	NULL
extraction	NULL
was	NULL
carried	NULL
out	NULL
within	NULL
one	NULL
month	NULL
of	NULL
the	NULL
storage	NULL
period	NULL
.	NULL

After	NULL
pulverisation	NULL
of	NULL
the	NULL
frozen	NULL
tissues	NULL
in	NULL
a	NULL
micro-homogeniser	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
,	NULL
USA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
,	NULL
precipitated	NULL
with	NULL
isopropanol	NULL
in	NULL
the	NULL
pressence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
glycogen	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
15	NULL
000	NULL
r.p.m	NULL
.	NULL

for	NULL
15	NULL
min	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
75	NULL
%	NULL
ethanol	NULL
,	NULL
dried	NULL
and	NULL
dissolved	NULL
in	NULL
diethyl	NULL
pyrocarbonate	NULL
(	NULL
DEPC	NULL
)	NULL
-treated	NULL
distilled	NULL
water	NULL
.	NULL

After	NULL
DNAase	NULL
I	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
treatment	NULL
at	NULL
37Â°C	NULL
for	NULL
15	NULL
min	NULL
followed	NULL
by	NULL
10	NULL
min	NULL
Table	NULL
I	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
Active	NULL
EBNA	NULL
promoter	NULL
LMP	NULL
BamHI-A	NULL
Case	NULL
no	NULL
-	NULL
Age	NULL
Sex	NULL
Histological	NULL
type	NULL
(	NULL
U/K	NULL
)	NULL
EBNA2	NULL
Cp	NULL
Wp	NULL
Qp	NULL
1	NULL
24	NULL
2B	NULL
transcripts	NULL
BZAL1	NULL
1	NULL
81	NULL
F	NULL
-	NULL
Undifferentiated	NULL
(	NULL
lym-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
a	NULL
+	NULL
phoepithelioma-like	NULL
)	NULL
2	NULL
55	NULL
M	NULL
-	NULL
Poorly	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
3	NULL
67	NULL
M	NULL
-	NULL
Poorly	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
4	NULL
71	NULL
M	NULL
-	NULL
Moderately	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
5	NULL
72	NULL
M	NULL
-	NULL
Moderately	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
6	NULL
55	NULL
M	NULL
-	NULL
Moderately	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
7	NULL
53	NULL
M	NULL
-	NULL
Well	NULL
differentiated	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Table	NULL
II	NULL
The	NULL
sequences	NULL
and	NULL
coordinates	NULL
of	NULL
primers	NULL
and	NULL
probes	NULL
used	NULL
in	NULL
this	NULL
study	NULL
Transcript	NULL
Product	NULL
size	NULL
Sequence	NULL
(	NULL
5-3	NULL
)	NULL
B95-8	NULL
genomic	NULL
coordinates	NULL
EBNA1	NULL
273	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
GATGAGCGTTTGGGAGAGCTGATTCTGCA	NULL
67510-67539	NULL
3	NULL
'	NULL
primer	NULL
TCCTCGTCCATGGTTATCAC	NULL
108075-108056	NULL
Probe	NULL
AGACCTGGGAGCAGATTCAC	NULL
67608-67627	NULL
EBNA2	NULL
339	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
GCTGCTACGCATTAGAGACC	NULL
47892-47911	NULL
3	NULL
'	NULL
primer	NULL
TCCTGGTAGGGATTCGAGGG	NULL
48616-48597	NULL
Probe	NULL
CAGCACTGGCGTGTGACGTGGTGTAAAGTT	NULL
48391-48420	NULL
Qp	NULL
initiated	NULL
339	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
AGGCGCGGGATAGCGTGCGCTACCGGA	NULL
62426-62452	NULL
3	NULL
'	NULL
primer	NULL
TCCTCGTCCATGGTTATCAC	NULL
108075-	NULL
108056	NULL
Probe	NULL
AGACCTGGGAGCAGATTCAC	NULL
67608-67627	NULL
Cp	NULL
initiated	NULL
297	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
CACTACAAGACCTACGCCTCTCCATCCATC	NULL
11425-11454	NULL
3	NULL
primer	NULL
TCTCCCCTAGGCCCTGAAGGTGAACCGCIT	NULL
14832-14813	NULL
,	NULL
17636-17626	NULL
Probe	NULL
GCGACCGGTGCCTTCTTAGGAGCTGTCCGA	NULL
14708-14737	NULL
Wp	NULL
initiated	NULL
235	NULL
bp	NULL
5'primer	NULL
TCAGAGCGCCAGGAGTCCACACAAAT	NULL
14384-14410	NULL
3	NULL
'	NULL
primer	NULL
TCTCCCCTAGGCCCTGAAGGTGAACCGCIT	NULL
14832-14813	NULL
,	NULL
17636-17626	NULL
Probe	NULL
GCGACCGGTGCCTTCTITTAGGAGCTGTCCGA	NULL
14708-14737	NULL
LMP1	NULL
490	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
TCCTCCTCTTGGCGCTACTG	NULL
169383-	NULL
169364	NULL
3	NULL
'	NULL
primer	NULL
TCATCACTGTGTCGTTGTCC	NULL
168740-168759	NULL
Probe	NULL
GAACAGCACAATTCCAAGGAACAATGCCTG	NULL
169061	NULL
-	NULL
169090	NULL
LMP2AÂ®	NULL
280	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
ATGACTCATCTCAACACATA	NULL
166874-166893	NULL
3	NULL
'	NULL
primer	NULL
CATGTTAGGCAAATTGCAAA	NULL
380-361	NULL
Probe	NULL
ATCCAGTATGCCTGCCTGTA	NULL
62-81	NULL
LMP2B*	NULL
325	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
CAGTGTAATCTGCACAAAGA	NULL
169838	NULL
3	NULL
'	NULL
primer	NULL
CATGTTAGGCAAATTGCAAA	NULL
380-361	NULL
Probe	NULL
ATCCAGTATGCCTGCCTGTA	NULL
62-81	NULL
BamHI-A	NULL
``	NULL
232	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
AGAGACCAGGCTGCTAAACA	NULL
157154-157174	NULL
3	NULL
'	NULL
primer	NULL
AACCAGCTTTCCTTTCCGAG	NULL
159194-159175	NULL
Probe	NULL
AAGACGTTGGAGGCACGCTG	NULL
157359-157378	NULL
BZLFI	NULL
453	NULL
bp	NULL
5	NULL
'	NULL
primer	NULL
CATGTTITTCAACCGCTCCGACTGG	NULL
102963-102941	NULL
3	NULL
'	NULL
primer	NULL
GCGCAGCCTGTCATTTITTCAGATG	NULL
102303	NULL
Probe	NULL
GCACGACGCACACGGAAACCACAACAGCCA	NULL
102661	NULL
-102690	NULL
``	NULL
Brooks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
``	NULL
Brooks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993.	NULL
heating	NULL
at	NULL
95Â°C	NULL
,	NULL
RNA	NULL
was	NULL
ethanol-precipitated	NULL
again	NULL
,	NULL
then	NULL
resuspended	NULL
in	NULL
DEPC-treated	NULL
water	NULL
and	NULL
dispensed	NULL
into	NULL
small	NULL
aliquots	NULL
.	NULL

To	NULL
test	NULL
the	NULL
sensitivity	NULL
of	NULL
our	NULL
RT-PCR	NULL
system	NULL
,	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
10Â°	NULL
appropriate	NULL
control	NULL
cells	NULL
,	NULL
serially	NULL
10-fold	NULL
diluted	NULL
from	NULL
a	NULL
quantity	NULL
equivalent	NULL
to	NULL
10Â°	NULL
to	NULL
10Â°	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
total	NULL
RNA	NULL
amount	NULL
of	NULL
each	NULL
diluted	NULL
sample	NULL
was	NULL
adjusted	NULL
to	NULL
that	NULL
of	NULL
10Â°	NULL
cells	NULL
by	NULL
addition	NULL
of	NULL
RNA	NULL
extracted	NULL
from	NULL
BJAB	NULL
cells	NULL
.	NULL

For	NULL
cDNA	NULL
synthesis	NULL
,	NULL
10	NULL
pmol	NULL
of	NULL
a	NULL
3'-primer	NULL
specific	NULL
for	NULL
each	NULL
transcript	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
RNA	NULL
sample	NULL
,	NULL
followed	NULL
by	NULL
heating	NULL
at	NULL
94Â°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
rapid	NULL
chilling	NULL
on	NULL
ice	NULL
.	NULL

Reagents	NULL
were	NULL
added	NULL
to	NULL
the	NULL
RNA	NULL
primer	NULL
mixture	NULL
to	NULL
give	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
75	NULL
mM	NULL
potassium	NULL
chloride	NULL
,	NULL
3	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
10	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mm	NULL
for	NULL
each	NULL
dNTP	NULL
,	NULL
10	NULL
U	NULL
of	NULL
RNasin	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
200	NULL
U	NULL
of	NULL
Molony	NULL
murine	NULL
leukaemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
.	NULL

Reverse	NULL
transcription	NULL
was	NULL
performed	NULL
at	NULL
37Â°C	NULL
for	NULL
60	NULL
min	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
and	NULL
then	NULL
heated	NULL
at	NULL
94Â°C	NULL
for	NULL
3	NULL
min	NULL
to	NULL
stop	NULL
the	NULL
reaction	NULL
.	NULL

PCR	NULL
and	NULL
detection	NULL
of	NULL
amplified	NULL
products	NULL
Full	NULL
details	NULL
of	NULL
the	NULL
sequences	NULL
and	NULL
genome	NULL
coordinates	NULL
of	NULL
primers	NULL
and	NULL
probes	NULL
used	NULL
to	NULL
detect	NULL
EBV	NULL
transcripts	NULL
are	NULL
given	NULL
in	NULL
Table	NULL
II	NULL
.	NULL

Our	NULL
original	NULL
primer	NULL
pairs	NULL
were	NULL
designed	NULL
in	NULL
different	NULL
exons	NULL
for	NULL
individual	NULL
EBV	NULL
transcripts	NULL
so	NULL
that	NULL
occasional	NULL
amplification	NULL
of	NULL
contaminated	NULL
genomic	NULL
DNA	NULL
,	NULL
if	NULL
any	NULL
,	NULL
could	NULL
be	NULL
easily	NULL
discriminated	NULL
from	NULL
the	NULL
relevant	NULL
RNA	NULL
amplification	NULL
by	NULL
product	NULL
size	NULL
.	NULL

The	NULL
PCR	NULL
reaction	NULL
mixture	NULL
consisted	NULL
of	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.4	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
potassium	NULL
chloride	NULL
,	NULL
1.5	NULL
mM	NULL
magnesium	NULL
chloride	NULL
,	NULL
0.01	NULL
%	NULL
gelatin	NULL
,	NULL
200	NULL
um	NULL
of	NULL
each	NULL
dNTP	NULL
,	NULL
20	NULL
pmol	NULL
of	NULL
each	NULL
primer	NULL
and	NULL
synthesised	NULL
--	NULL
-EBNA1	NULL
for	NULL
Mc	NULL
?	NULL

K	NULL
<	NULL
4	NULL
:	NULL
K	NULL
a	NULL
afe	NULL
us	NULL
Wp	NULL
wi	NULL
I	NULL
&	NULL
_	NULL
>	NULL
Wo	NULL
OD	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
cDNA	NULL
,	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
ul	NULL
.	NULL

After	NULL
it	NULL
was	NULL
overlaid	NULL
with	NULL
mineral	NULL
oil	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
heated	NULL
to	NULL
94Â°C	NULL
for	NULL
3	NULL
min	NULL
,	NULL
slowly	NULL
cooled	NULL
to	NULL
70Â°C	NULL
,	NULL
and	NULL
then	NULL
2.5	NULL
U	NULL
of	NULL
Tag	NULL
polymerase	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
tubes	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
35	NULL
cycles	NULL
of	NULL
amplification	NULL
by	NULL
a	NULL
Thermal	NULL
Cycler	NULL
480	NULL
(	NULL
Perkin-Elmer	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
each	NULL
cycle	NULL
consisting	NULL
of	NULL
94Â°C	NULL
for	NULL
1	NULL
min	NULL
(	NULL
denaturation	NULL
)	NULL
,	NULL
45Â°C	NULL
for	NULL
2	NULL
min	NULL
(	NULL
annealing	NULL
)	NULL
and	NULL
72Â°C	NULL
for	NULL
3	NULL
min	NULL
(	NULL
DNA	NULL
extension	NULL
)	NULL
.	NULL

The	NULL
extension	NULL
time	NULL
was	NULL
prolonged	NULL
to	NULL
6	NULL
min	NULL
in	NULL
the	NULL
last	NULL
cycle	NULL
.	NULL

The	NULL
quality	NULL
of	NULL
RNA	NULL
preparations	NULL
was	NULL
simultaneously	NULL
checked	NULL
by	NULL
30	NULL
cycles	NULL
of	NULL
amplification	NULL
of	NULL
cytoplasmic	NULL
B-actin	NULL
mRNA	NULL
with	NULL
the	NULL
antisense	NULL
primer	NULL
(	NULL
5-GGAGCAAT-GATCITGATCTTC-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
sense	NULL
primer	NULL
(	NULL
5'-CCTTCCTGGGCATGGAGTCCT-3	NULL
'	NULL
)	NULL
(	NULL
Busson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
electrophoresed	NULL
in	NULL
1.5	NULL
%	NULL
agarose	NULL
gels	NULL
(	NULL
SeaKem	NULL
;	NULL
Takara	NULL
,	NULL
Otsu	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
(	NULL
Et-Br	NULL
)	NULL
,	NULL
and	NULL
photographed	NULL
under	NULL
a	NULL
UV-transillumi-nator	NULL
.	NULL

They	NULL
were	NULL
denatured	NULL
in	NULL
an	NULL
alkali	NULL
solution	NULL
for	NULL
20	NULL
min	NULL
with	NULL
gentle	NULL
rocking	NULL
and	NULL
directly	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Biodyne-B	NULL
;	NULL
Pall	NULL
,	NULL
Glen	NULL
Cove	NULL
,	NULL
NY	NULL
,	NULL
USA	NULL
)	NULL
by	NULL
vacuum	NULL
transfer	NULL
.	NULL

The	NULL
blotted	NULL
membranes	NULL
were	NULL
fixed	NULL
with	NULL
a	NULL
UV-crosslinker	NULL
(	NULL
Bio	NULL
Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
hybridisation	NULL
with	NULL
[	NULL
y-P	NULL
]	NULL
JATP-S'-end-labelled	NULL
internal	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

The	NULL
exposure	NULL
time	NULL
of	NULL
autoradiograph	NULL
was	NULL
6-12	NULL
h	NULL
for	NULL
viral	NULL
transcripts	NULL
and	NULL
2	NULL
h	NULL
for	NULL
B-actin	NULL
mRNA	NULL
.	NULL

Immunofluorescence	NULL
assay	NULL
Frozen	NULL
tissue	NULL
sections	NULL
of	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
were	NULL
examined	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
BZLFl	NULL
protein	NULL
by	NULL
streptavidin	NULL
immunofluorescence	NULL
,	NULL
using	NULL
mouse	NULL
BZ.1	NULL
LMP	NULL
1	NULL
EBNA2	NULL
Cp	NULL
;	NULL
reac	NULL
;	NULL
[	NULL
C2	NULL
\	NULL
=p	NULL
=n	NULL
<	NULL
=	NULL
memï¬	NULL
â	NULL
``	NULL
[	NULL
wo	NULL
]	NULL
B-Actin	NULL
1.2.3	NULL
204	NULL
2/5400	NULL
.7	NULL
-M	NULL
09	NULL
210	NULL
202	NULL
op	NULL
>	NULL
Lea	NULL
P	NULL
CTP	NULL
``	NULL
I	NULL
1	NULL
_	NULL
Figure	NULL
1	NULL
-	NULL
Detection	NULL
of	NULL
EBNA1	NULL
,	NULL
EBNAZ	NULL
and	NULL
LMP1	NULL
mRNAs	NULL
by	NULL
RT-PCR	NULL
in	NULL
EBV-positive	NULL
and	NULL
-negative	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
by	NULL
ethidium	NULL
bromide	NULL
(	NULL
Et-Br	NULL
)	NULL
staining	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
Southern	NULL
hybridisation	NULL
with	NULL
**P-labelled	NULL
probes	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
@	NULL
X174-Haelll	NULL
digest	NULL
as	NULL
a	NULL
size	NULL
marker	NULL
;	NULL
lane	NULL
P	NULL
,	NULL
PCR	NULL
product	NULL
of	NULL
RNA	NULL
extracted	NULL
from	NULL
LCL	NULL
as	NULL
an	NULL
EBV-positive	NULL
control	NULL
;	NULL
lanes	NULL
1	NULL
7	NULL
,	NULL
PCR	NULL
products	NULL
of	NULL
RNAs	NULL
from	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
of	NULL
case	NULL
nos	NULL
.	NULL

1-7	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
respectively	NULL
;	NULL
lanes	NULL
8-10	NULL
,	NULL
PCR	NULL
products	NULL
of	NULL
RNAs	NULL
extracted	NULL
from	NULL
three	NULL
EBV-negative	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
(	NULL
well-differentiated	NULL
,	NULL
moderately	NULL
differentiated	NULL
and	NULL
poorly	NULL
differentiated	NULL
types	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
splice	NULL
structures	NULL
of	NULL
each	NULL
transcript	NULL
analysed	NULL
are	NULL
shown	NULL
by	NULL
diagrams	NULL
on	NULL
the	NULL
top	NULL
of	NULL
Et-Br-stained	NULL
gels	NULL
.	NULL

Open	NULL
boxes	NULL
and	NULL
small	NULL
arrows	NULL
represent	NULL
exons	NULL
and	NULL
the	NULL
sites	NULL
of	NULL
relevant	NULL
transcriptional	NULL
EBNA	NULL
promoters	NULL
respectively	NULL
.	NULL

The	NULL
primer-probe	NULL
combinations	NULL
used	NULL
are	NULL
indicated	NULL
as	NULL
large	NULL
arrows	NULL
and	NULL
bars	NULL
.	NULL

Simultaneous	NULL
amplification	NULL
of	NULL
cytoplasmic	NULL
A-actin	NULL
mRNA	NULL
was	NULL
carried	NULL
out	NULL
to	NULL
check	NULL
for	NULL
pertinent	NULL
RNA	NULL
extraction	NULL
.	NULL

The	NULL
predicted	NULL
sizes	NULL
of	NULL
each	NULL
viral	NULL
transcript	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
(	NULL
bp	NULL
)	NULL
.	NULL

627	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
628	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Young	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
purchased	NULL
from	NULL
Dakopatts	NULL
)	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
,	NULL
B95-8	NULL
cells	NULL
or	NULL
surface	NULL
IgG-cross-linked	NULL
Akata	NULL
cells	NULL
served	NULL
as	NULL
a	NULL
BZLFIl-positive	NULL
control	NULL
,	NULL
and	NULL
non-treated	NULL
Akata	NULL
cells	NULL
and	NULL
EBV-negative	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
served	NULL
as	NULL
the	NULL
negative	NULL
controls	NULL
.	NULL

Results	NULL
Sensitivity	NULL
of	NULL
RT-PCR	NULL
In	NULL
preliminary	NULL
experiments	NULL
using	NULL
diluted	NULL
RNA	NULL
samples	NULL
from	NULL
a	NULL
reference	NULL
LCL	NULL
,	NULL
the	NULL
RT-PCR	NULL
-Southern	NULL
hybridisation	NULL
system	NULL
with	NULL
our	NULL
original	NULL
primer-probe	NULL
combinations	NULL
could	NULL
detect	NULL
EBNA1	NULL
(	NULL
with	NULL
U/K	NULL
exons	NULL
)	NULL
,	NULL
EBNA2	NULL
,	NULL
LMP	NULL
!	NULL

1	NULL
,	NULL
BARFO	NULL
and	NULL
Cp-initiated	NULL
EBNA	NULL
transcripts	NULL
as	NULL
well	NULL
as	NULL
LMP2A	NULL
and	NULL
-2B	NULL
mRNAs	NULL
amplified	NULL
with	NULL
the	NULL
primers	NULL
previously	NULL
reported	NULL
(	NULL
Brooks	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
even	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Wp-	NULL
and	NULL
Qp-initiated	NULL
EBNA	NULL
and	NULL
BZLFI	NULL
mRNAs	NULL
were	NULL
detectable	NULL
at	NULL
RNA	NULL
amounts	NULL
equivalent	NULL
to	NULL
10	NULL
LCL	NULL
,	NULL
untreated	NULL
and	NULL
slg-crosslinked	NULL
Akata	NULL
cells	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
RT-PCR	NULL
systems	NULL
were	NULL
considered	NULL
to	NULL
have	NULL
sensitivities	NULL
similar	NULL
to	NULL
or	NULL
higher	NULL
than	NULL
those	NULL
described	NULL
in	NULL
other	NULL
RNA	NULL
studies	NULL
on	NULL
NPC	NULL
and	NULL
HD	NULL
(	NULL
Brooks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Deacon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
EBV	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
RT-PCR	NULL
analyses	NULL
revealed	NULL
that	NULL
EBNAl	NULL
mRNA	NULL
with	NULL
BamHI-U	NULL
and	NULL
-K	NULL
exons	NULL
,	NULL
which	NULL
are	NULL
commonly	NULL
contained	NULL
in	NULL
every	NULL
EBNA1	NULL
transcript	NULL
generated	NULL
from	NULL
any	NULL
of	NULL
the	NULL
three	NULL
EBNA	NULL
promoters	NULL
,	NULL
could	NULL
be	NULL
clearly	NULL
detected	NULL
in	NULL
all	NULL
seven	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
none	NULL
of	NULL
the	NULL
tumour	NULL
tissues	NULL
expressed	NULL
either	NULL
detectable	NULL
EBNA2	NULL
or	NULL
LMP	NULL
!	NULL

mRNA	NULL
,	NULL
whereas	NULL
the	NULL
RNA	NULL
preparation	NULL
from	NULL
control	NULL
LCL	NULL
yielded	NULL
strong	NULL
signals	NULL
and	NULL
$	NULL
-actin	NULL
mRNA	NULL
was	NULL
readily	NULL
amplified	NULL
from	NULL
all	NULL
tumour	NULL
tissues	NULL
tested	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
observations	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
(	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
expression	NULL
of	NULL
LMP2A	NULL
,	NULL
-2B	NULL
and	NULL
BamHI-A	NULL
transcripts	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
,	NULL
which	NULL
remain	NULL
unknown	NULL
so	NULL
far	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2	NULL
,	NULL
LMP2A	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
three	NULL
of	NULL
the	NULL
seven	NULL
cases	NULL
,	NULL
although	NULL
LMP2B	NULL
mRNA	NULL
was	NULL
undetectable	NULL
in	NULL
all	NULL
cases	NULL
.	NULL

Transcripts	NULL
from	NULL
the	NULL
BamHI-A	NULL
fragment	NULL
of	NULL
the	NULL
virus	NULL
genomes	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
all	NULL
seven	NULL
cases	NULL
studied	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
above	NULL
results	NULL
,	NULL
the	NULL
EBV	NULL
latent	NULL
gene	NULL
expression	NULL
pattern	NULL
in	NULL
gastric	NULL
carcinoma	NULL
is	NULL
delineated	NULL
in	NULL
Table	NULL
III	NULL
,	NULL
in	NULL
comparison	NULL
with	NULL
the	NULL
other	NULL
representative	NULL
EBV-positive	NULL
cell	NULL
types	NULL
.	NULL

No	NULL
mRNA	NULL
investigated	NULL
except	NULL
for	NULL
B-actin	NULL
was	NULL
detected	NULL
in	NULL
six	NULL
EBV-negative	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
throughout	NULL
the	NULL
present	NULL
study	NULL
(	NULL
Figure	NULL
1	NULL
and	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Promoter	NULL
utilisation	NULL
for	NULL
EBNA	NULL
transcription	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
Since	NULL
the	NULL
unequivocal	NULL
detection	NULL
of	NULL
U/K-spliced	NULL
EBNA1I	NULL
mRNA	NULL
with	NULL
the	NULL
concomitant	NULL
absence	NULL
of	NULL
EBNA2	NULL
mRNA	NULL
suggested	NULL
Qp-driven	NULL
EBNA	NULL
transcription	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
which	NULL
of	NULL
the	NULL
three	NULL
EBNA	NULL
promoters	NULL
actually	NULL
mediated	NULL
EBNA	NULL
gene	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
EBNA	NULL
mRNA	NULL
with	NULL
the	NULL
Q/U/K-spliced	NULL
structure	NULL
was	NULL
clearly	NULL
detected	NULL
in	NULL
all	NULL
cases	NULL
tested	NULL
,	NULL
whereas	NULL
mRNA	NULL
with	NULL
C1/W2	NULL
or	NULL
WO/W2	NULL
exons	NULL
,	NULL
diagnostic	NULL
of	NULL
Cp	NULL
and	NULL
Wp	NULL
usage	NULL
,	NULL
respectively	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
at	NULL
all	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
Q/U/K	NULL
exon-containing	NULL
EBNA1	NULL
transcript	NULL
detected	NULL
here	NULL
was	NULL
initiated	NULL
from	NULL
the	NULL
BamHI-F	NULL
promoter	NULL
(	NULL
Fp	NULL
)	NULL
,	NULL
which	NULL
was	NULL
initially	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
third	NULL
EBNA	NULL
promoter	NULL
(	NULL
Schaefer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Sample	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
and	NULL
redefined	NULL
thereafter	NULL
as	NULL
an	NULL
early	NULL
lytic	NULL
promoter	NULL
(	NULL
Lear	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Schaefer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
LMP2B	NULL
R	NULL
325	NULL
bp	NULL
posed	NULL
uP	NULL
__	NULL
um	NULL
<	NULL
a	NULL
transcript	NULL
1	NULL
<	NULL
5	NULL
6	NULL
I	NULL
232	NULL
bp	NULL
Â»	NULL
Isas	NULL
â	NULL
*	NULL
Inoue	NULL
Figure	NULL
2	NULL
Detection	NULL
of	NULL
LMP2A	NULL
,	NULL
LMP2B	NULL
and	NULL
BamHI-A	NULL
transcripts	NULL
by	NULL
RT-PCR	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
by	NULL
Et-Br	NULL
staining	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
Southern	NULL
hybridisation	NULL
with	NULL
Â°	NULL
``	NULL
P-labelled	NULL
probes	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

The	NULL
splice	NULL
structures	NULL
of	NULL
each	NULL
transcript	NULL
are	NULL
shown	NULL
by	NULL
diagrams	NULL
on	NULL
the	NULL
top	NULL
of	NULL
Et-Br-stained	NULL
gels	NULL
.	NULL

Diagrammatic	NULL
items	NULL
and	NULL
lanes	NULL
represent	NULL
the	NULL
same	NULL
ones	NULL
as	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
predicted	NULL
sizes	NULL
of	NULL
viral	NULL
transcripts	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
(	NULL
bp	NULL
)	NULL
.	NULL

Table	NULL
III	NULL
EBV	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
Type	NULL
of	NULL
EBN	NULL
A	NULL
Active	NULL
EBNA	NULL
promoter	NULL
LMP	NULL
BamFHI-A	NULL
Cell	NULL
type	NULL
EBV	NULL
latency	NULL
1	NULL
2,3s	NULL
,	NULL
LP	NULL
_	NULL
Cp	NULL
or	NULL
Wp	NULL
Qp	NULL
1	NULL
24	NULL
2B	NULL
transcript	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
I	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
Nasopharyngeal	NULL
carcinoma	NULL
II	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
4	NULL
+	NULL
Hodgkin	NULL
's	NULL
disease	NULL
II	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
T-cell	NULL
lymphoma	NULL
II	NULL
+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
III	NULL
+	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
B-lymphoproliferation	NULL
III	NULL
+	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
in	NULL
immunodeficiency	NULL
Gastric	NULL
carcinoma	NULL
+	NULL
-	NULL
_-	NULL
+	NULL
no	NULL
_	NULL
4	NULL
``	NULL
Positive	NULL
in	NULL
3/7	NULL
(	NULL
43	NULL
%	NULL
)	NULL
cases	NULL
.	NULL

1995b	NULL
)	NULL
,	NULL
because	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
Fp-initiated	NULL
lytic	NULL
transcripts	NULL
appeared	NULL
not	NULL
to	NULL
contain	NULL
the	NULL
K	NULL
exon	NULL
(	NULL
Schaefer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
@	NULL
and	NULL
b	NULL
)	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
all	NULL
tumour	NULL
tissues	NULL
examined	NULL
showed	NULL
no	NULL
evidence	NULL
of	NULL
lytic	NULL
infection	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
indicated	NULL
that	NULL
Qp	NULL
,	NULL
not	NULL
Cp	NULL
or	NULL
Wp	NULL
,	NULL
mediated	NULL
EBNA	NULL
transcription	NULL
in	NULL
gastric	NULL
carcinoma	NULL
.	NULL

Analyses	NULL
of	NULL
BZLFI	NULL
gene	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
Figure	NULL
4	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
RT-PCR	NULL
analysis	NULL
demonstrating	NULL
that	NULL
none	NULL
of	NULL
the	NULL
tumours	NULL
showed	NULL
evidence	NULL
for	NULL
expression	NULL
of	NULL
BZLFl	NULL
mRNA	NULL
.	NULL

Similar	NULL
negative	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
by	NULL
immunofluorescent	NULL
staining	NULL
with	NULL
the	NULL
BZ.1	NULL
monoclonal	NULL
antibody	NULL
in	NULL
frozen	NULL
tissue	NULL
sections	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
our	NULL
RT-PCR	NULL
system	NULL
for	NULL
detection	NULL
of	NULL
BZLFI	NULL
mRNA	NULL
was	NULL
sensitive	NULL
enough	NULL
to	NULL
detect	NULL
ten	NULL
or	NULL
fewer	NULL
Akata	NULL
cells	NULL
treated	NULL
by	NULL
surface	NULL
IgG	NULL
cross-linking	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
in	NULL
which	NULL
more	NULL
than	NULL
80	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
positive	NULL
for	NULL
the	NULL
BZLFI	NULL
antigen	NULL
,	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
was	NULL
assumed	NULL
to	NULL
harbour	NULL
EBV	NULL
in	NULL
a	NULL
non-permissive	NULL
form	NULL
.	NULL

Discussion	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
one	NULL
of	NULL
the	NULL
three	NULL
hitherto	NULL
identified	NULL
EBNA	NULL
promoters	NULL
,	NULL
Qp	NULL
,	NULL
was	NULL
used	NULL
in	NULL
EBV	NULL
Cp	NULL
297	NULL
bp	NULL
Â»	NULL
Wp	NULL
235	NULL
bp	NULL
Â»	NULL
p	NULL
[	NULL
â	NULL
[	NULL
ï¬	NULL
e	NULL
M0	NULL
f	NULL
``	NULL
~	NULL
>	NULL
M	NULL
:	NULL
b	NULL
4	NULL
.	NULL

12..3	NULL
.	NULL

4	NULL
ze	NULL
wI	NULL
.	NULL

8-0	NULL
:	NULL
ag	NULL
Op	NULL
339	NULL
bp	NULL
Â»	NULL
Figure	NULL
3	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
promoter	NULL
usage	NULL
for	NULL
EBNA	NULL
gene	NULL
transcription	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
by	NULL
Et-Br	NULL
staining	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
Southern	NULL
hybridisation	NULL
with	NULL
*Â°P-labelled	NULL
probes	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

The	NULL
structures	NULL
of	NULL
EBNA	NULL
mRNA	NULL
transcribed	NULL
from	NULL
the	NULL
three	NULL
different	NULL
promoters	NULL
Cp	NULL
,	NULL
Wp	NULL
and	NULL
Qp	NULL
are	NULL
shown	NULL
by	NULL
diagrams	NULL
.	NULL

Diagrammatic	NULL
items	NULL
and	NULL
lanes	NULL
represent	NULL
the	NULL
same	NULL
ones	NULL
as	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
predicted	NULL
sizes	NULL
of	NULL
each	NULL
transcript	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
(	NULL
bp	NULL
)	NULL
.	NULL

EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
positive	NULL
gastric	NULL
carcinomas	NULL
,	NULL
thus	NULL
resulting	NULL
in	NULL
the	NULL
selective	NULL
expression	NULL
of	NULL
EBNA1	NULL
mRNA	NULL
,	NULL
but	NULL
not	NULL
EBNA2Z	NULL
mRNA	NULL
,	NULL
as	NULL
is	NULL
seen	NULL
in	NULL
BL	NULL
and	NULL
NPC	NULL
(	NULL
Liebowitz	NULL
and	NULL
Kieff	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
neither	NULL
LMPI	NULL
nor	NULL
LMP2B	NULL
mRNA	NULL
was	NULL
detectable	NULL
in	NULL
any	NULL
case	NULL
examined	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
showing	NULL
by	NULL
immunoblotting	NULL
that	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
cells	NULL
lacked	NULL
EBNA2	NULL
,	NULL
-3A	NULL
,	NULL
-3B	NULL
,	NULL
3C	NULL
,	NULL
-LP	NULL
and	NULL
LMP1	NULL
proteins	NULL
(	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

All	NULL
seven	NULL
EBV-positive	NULL
tumours	NULL
were	NULL
also	NULL
found	NULL
to	NULL
have	NULL
BamHI-A	NULL
transcripts	NULL
together	NULL
with	NULL
the	NULL
EBNA1l	NULL
message	NULL
,	NULL
presumably	NULL
corresponding	NULL
to	NULL
latency	NULL
I	NULL
of	NULL
EBV	NULL
infection	NULL
typified	NULL
by	NULL
group	NULL
I	NULL
BL	NULL
cells	NULL
(	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
LMP2A	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
three	NULL
of	NULL
seven	NULL
cases	NULL
tested	NULL
,	NULL
which	NULL
may	NULL
represent	NULL
a	NULL
novel	NULL
latency	NULL
of	NULL
EBV-related	NULL
tumours	NULL
distinct	NULL
from	NULL
conventional	NULL
latency	NULL
I	NULL
or	NULL
II	NULL
(	NULL
Kerr	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
this	NULL
uniquely	NULL
restricted	NULL
pattern	NULL
of	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
subgroup	NULL
of	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
mostly	NULL
resembled	NULL
that	NULL
observed	NULL
in	NULL
peripheral	NULL
blood	NULL
B	NULL
lymphocytes	NULL
of	NULL
healthy	NULL
EBV-seropositive	NULL
individuals	NULL
(	NULL
Qu	NULL
and	NULL
Rowe	NULL
,	NULL
1992	NULL
;	NULL
Tierney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
which	NULL
would	NULL
be	NULL
advantageous	NULL
for	NULL
maintaining	NULL
the	NULL
life-long	NULL
virus	NULL
carrier	NULL
state	NULL
under	NULL
effective	NULL
immunity	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
by	NULL
using	NULL
an	NULL
isogenic	NULL
system	NULL
of	NULL
group	NULL
I	NULL
BL	NULL
cells	NULL
that	NULL
EBV	NULL
indeed	NULL
contributes	NULL
to	NULL
the	NULL
malignant	NULL
phenotypes	NULL
(	NULL
Shimizu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
since	NULL
EBNA1I	NULL
,	NULL
the	NULL
putative	NULL
BamHI-A	NULL
product	NULL
and	NULL
EBERs	NULL
are	NULL
commonly	NULL
expressed	NULL
both	NULL
in	NULL
group	NULL
I	NULL
BL	NULL
and	NULL
in	NULL
gastric	NULL
carcinoma	NULL
cells	NULL
,	NULL
they	NULL
may	NULL
also	NULL
be	NULL
responsible	NULL
,	NULL
to	NULL
some	NULL
extent	NULL
,	NULL
for	NULL
the	NULL
malignant	NULL
features	NULL
of	NULL
gastric	NULL
carcinoma	NULL
.	NULL

Recently	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
in	NULL
the	NULL
EBV-induced	NULL
oncogenic	NULL
process	NULL
has	NULL
been	NULL
proposed	NULL
in	NULL
that	NULL
its	NULL
Gly-Ala	NULL
repetitive	NULL
sequence	NULL
inhibited	NULL
the	NULL
specific	NULL
cytotoxic	NULL
T-cell	NULL
recognition	NULL
of	NULL
immunodominant	NULL
EBNA3B	NULL
through	NULL
a	NULL
cis-acting	NULL
mode	NULL
(	NULL
Levitskaya	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Several	NULL
in	NULL
vitro	NULL
studies	NULL
,	NULL
however	NULL
,	NULL
demonstrated	NULL
that	NULL
LMP1	NULL
potentially	NULL
confers	NULL
tumorigenicity	NULL
on	NULL
non-lymphoid	NULL
cells	NULL
via	NULL
transformation	NULL
of	NULL
established	NULL
rodent	NULL
fibroblasts	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
and	NULL
human	NULL
keratinocytes	NULL
(	NULL
Fahraeus	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
human	NULL
epithelial	NULL
cell	NULL
differentiation	NULL
(	NULL
Dawson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
functional	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Such	NULL
important	NULL
findings	NULL
strongly	NULL
support	NULL
crucial	NULL
roles	NULL
for	NULL
LMP1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
undifferentiated	NULL
NPC	NULL
,	NULL
where	NULL
the	NULL
LMP1I	NULL
positivity	NULL
exceeds	NULL
80	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
at	NULL
the	NULL
trancriptional	NULL
level	NULL
(	NULL
Brooks	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
lack	NULL
of	NULL
LMP1	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
,	NULL
irrespective	NULL
of	NULL
their	NULL
histological	NULL
phenotypes	NULL
,	NULL
implies	NULL
that	NULL
LMPI	NULL
may	NULL
not	NULL
be	NULL
necessary	NULL
for	NULL
the	NULL
tumour	NULL
,	NULL
at	NULL
least	NULL
to	NULL
sustain	NULL
its	NULL
already	NULL
established	NULL
malignant	NULL
state	NULL
.	NULL

Rather	NULL
,	NULL
LMPI1	NULL
might	NULL
participate	NULL
in	NULL
an	NULL
earlier	NULL
stage	NULL
of	NULL
the	NULL
tumour	NULL
development	NULL
and	NULL
be	NULL
down-regulated	NULL
thereafter	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
LMPI	NULL
may	NULL
reflect	NULL
the	NULL
result	NULL
of	NULL
BZLF1	NULL
3	NULL
Figure	NULL
4	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
immediate-early	NULL
BZLF1	NULL
gene	NULL
expression	NULL
in	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
.	NULL

Results	NULL
are	NULL
shown	NULL
by	NULL
Et-Br	NULL
staining	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
Southern	NULL
hybridisation	NULL
with	NULL
a	NULL
*Â°P-labelled	NULL
prope	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

The	NULL
splice	NULL
structure	NULL
of	NULL
BZLFI	NULL
mRNA	NULL
is	NULL
shown	NULL
by	NULL
a	NULL
diagram	NULL
on	NULL
the	NULL
top	NULL
of	NULL
an	NULL
Et-Br-stained	NULL
gel	NULL
.	NULL

Diagrammatic	NULL
items	NULL
and	NULL
lanes	NULL
represent	NULL
the	NULL
same	NULL
ones	NULL
as	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
predicted	NULL
size	NULL
of	NULL
BZLFI	NULL
mRNA	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
(	NULL
bp	NULL
)	NULL
.	NULL

629	NULL
bss	NULL
EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
clonal	NULL
selection	NULL
of	NULL
tumour	NULL
cells	NULL
by	NULL
immuno-logical	NULL
pressure	NULL
because	NULL
EBV-specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
are	NULL
potentially	NULL
directed	NULL
against	NULL
the	NULL
viral	NULL
latent	NULL
proteins	NULL
other	NULL
than	NULL
EBNA1	NULL
(	NULL
Khanna	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Murray	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
patients	NULL
with	NULL
EBV-positive	NULL
gastric	NULL
carcinoma	NULL
have	NULL
normally	NULL
retained	NULL
virus-specific	NULL
immune	NULL
T-cell	NULL
responses	NULL
(	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
as	NULL
is	NULL
the	NULL
case	NULL
with	NULL
BL	NULL
(	NULL
Rooney	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
NPC	NULL
patients	NULL
(	NULL
Moss	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
.	NULL

The	NULL
EBV	NULL
replication	NULL
can	NULL
be	NULL
switched	NULL
on	NULL
in	NULL
malignant	NULL
or	NULL
non-malignant	NULL
epithelial	NULL
proliferative	NULL
lesions	NULL
in	NULL
vivo	NULL
;	NULL
the	NULL
immediate-early	NULL
BZLF1	NULL
,	NULL
the	NULL
early	NULL
and/or	NULL
late	NULL
antigens	NULL
were	NULL
detected	NULL
in	NULL
NPC	NULL
(	NULL
Cochet	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
thymic	NULL
carcinoma	NULL
(	NULL
Patton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
AIDS-associated	NULL
oral	NULL
hairy	NULL
leucoplakia	NULL
(	NULL
OHL	NULL
)	NULL
(	NULL
Greenspan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Similar	NULL
viral	NULL
cycle	NULL
events	NULL
were	NULL
also	NULL
observed	NULL
in	NULL
vitro	NULL
by	NULL
experimental	NULL
EBV	NULL
infection	NULL
of	NULL
cells	NULL
of	NULL
epithelial	NULL
origin	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sixbey	NULL
and	NULL
Yao	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
report	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
EBV-positive	NULL
undifferentiated	NULL
gastric	NULL
carcinoma	NULL
,	NULL
in	NULL
which	NULL
a	NULL
very	NULL
small	NULL
proportion	NULL
of	NULL
tumour	NULL
cells	NULL
expressed	NULL
the	NULL
BZLFI	NULL
protein	NULL
,	NULL
indicating	NULL
that	NULL
rare	NULL
gastric	NULL
carcinoma	NULL
cells	NULL
can	NULL
potentially	NULL
enter	NULL
the	NULL
lytic	NULL
cycle	NULL
(	NULL
Niedobitek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
in	NULL
contrast	NULL
,	NULL
showed	NULL
that	NULL
neither	NULL
the	NULL
BZLFI	NULL
mRNA	NULL
nor	NULL
protein	NULL
was	NULL
found	NULL
in	NULL
gastric	NULL
carcinoma	NULL
tissues	NULL
,	NULL
results	NULL
compatible	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
early	NULL
and	NULL
viral	NULL
capsid	NULL
antigens	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
Imai	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
although	NULL
EBV	NULL
latency	NULL
can	NULL
be	NULL
disrupted	NULL
as	NULL
epithelial	NULL
cells	NULL
differentiate	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
observations	NULL
in	NULL
OHL	NULL
(	NULL
Young	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
none	NULL
of	NULL
the	NULL
gastric	NULL
carcinomas	NULL
with	NULL
various	NULL
differentiations	NULL
showed	NULL
any	NULL
evidence	NULL
of	NULL
virus	NULL
production	NULL
.	NULL

LMP2A	NULL
,	NULL
detectably	NULL
expressed	NULL
in	NULL
three	NULL
of	NULL
our	NULL
seven	NULL
cases	NULL
,	NULL
was	NULL
References	NULL
BROOKS	NULL
L	NULL
,	NULL
YAO	NULL
QY	NULL
,	NULL
RICKINSON	NULL
AB	NULL
AND	NULL
YOUNG	NULL
LS	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
transcription	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
cells	NULL
:	NULL
coexpression	NULL
of	NULL
EBNA1	NULL
,	NULL
LMP1	NULL
,	NULL
and	NULL
LMP2	NULL
transcripts	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
2689-2697	NULL
.	NULL

BROOKS	NULL
LA	NULL
,	NULL
LEAR	NULL
AL	NULL
,	NULL
YOUNG	NULL
LS	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Transcripts	NULL
from	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BamHI	NULL
A	NULL
fragment	NULL
are	NULL
detectable	NULL
in	NULL
all	NULL
three	NULL
forms	NULL
of	NULL
virus	NULL
latency	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
3182-3190	NULL
.	NULL

BUSSON	NULL
P	NULL
,	NULL
CCCOY	NULL
R	NULL
,	NULL
SADLER	NULL
R	NULL
,	NULL
GILLIGAN	NULL
K	NULL
,	NULL
TURSZ	NULL
T	NULL
AND	NULL
RAAB-TRAUB	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Consistent	NULL
transcription	NULL
of	NULL
the	NULL
Epstein	NULL
Barr	NULL
virus	NULL
LMP2	NULL
gene	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
3257-3262	NULL
.	NULL

CHEN	NULL
F	NULL
,	NULL
HU	NULL
LF	NULL
,	NULL
ERNBERG	NULL
I	NULL
,	NULL
KLEIN	NULL
G	NULL
AND	NULL
WINBERG	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Coupled	NULL
transcription	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP	NULL
)	NULL
-1	NULL
and	NULL
LMP-2B	NULL
genes	NULL
in	NULL
nasopharyngeal	NULL
carcinomas	NULL
.	NULL

J.	NULL
Gen	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
76	NULL
,	NULL
131-138	NULL
.	NULL

COCHET	NULL
C	NULL
,	NULL
MARTEL	NULL
RD	NULL
,	NULL
GRUNEWALD	NULL
v	NULL
,	NULL
BOSQ	NULL
J	NULL
,	NULL
COCHET	NULL
G	NULL
,	NULL
SCHWAAB	NULL
G	NULL
,	NULL
BERNAUDIN	NULL
JF	NULL
AND	NULL
JOAB	NULL
I	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
immediate	NULL
early	NULL
gene	NULL
,	NULL
BZLFI	NULL
,	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
tumor	NULL
cells	NULL
.	NULL

Virology	NULL
,	NULL
197	NULL
,	NULL
358-365	NULL
.	NULL

COUNTRYMAN	NULL
J	NULL
,	NULL
JENSON	NULL
H	NULL
,	NULL
SEIBL	NULL
R	NULL
,	NULL
WOLF	NULL
H	NULL
AND	NULL
MILLER	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Polymorphic	NULL
proteins	NULL
encoded	NULL
within	NULL
BZLFI	NULL
of	NULL
defective	NULL
and	NULL
standard	NULL
Epstein-Barr	NULL
viruses	NULL
disrupt	NULL
latency	NULL
.	NULL

J	NULL
.	NULL

Viro/	NULL
.	NULL

,	NULL
61	NULL
,	NULL
3672-3679	NULL
.	NULL

DAWSON	NULL
CW	NULL
,	NULL
RICKINSON	NULL
AB	NULL
AND	NULL
YOUNG	NULL
LS	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
inhibits	NULL
human	NULL
epithelial	NULL
cell	NULL
differentiation	NULL
.	NULL

Nature	NULL
,	NULL
344	NULL
,	NULL
777-780	NULL
.	NULL

DEACON	NULL
EM	NULL
,	NULL
PALLESEN	NULL
G	NULL
,	NULL
NIEDOBITEK	NULL
G	NULL
,	NULL
CROCKER	NULL
J	NULL
,	NULL
BROOKS	NULL
L	NULL
,	NULL
RICKINSON	NULL
AB	NULL
AND	NULL
YOUNG	NULL
LS	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
transcriptional	NULL
analysis	NULL
of	NULL
virus	NULL
latency	NULL
in	NULL
the	NULL
malignant	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
177	NULL
,	NULL
339-349	NULL
.	NULL

DIMERY	NULL
IW	NULL
,	NULL
LEE	NULL
JS	NULL
,	NULL
BLICK	NULL
M	NULL
,	NULL
PEARSON	NULL
G	NULL
,	NULL
SPITZER	NULL
G	NULL
AND	NULL
HONG	NULL
WK	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

Association	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
with	NULL
lymphoepithelioma	NULL
of	NULL
the	NULL
thymus	NULL
.	NULL

Cancer	NULL
,	NULL
61	NULL
,	NULL
2475-2480	NULL
.	NULL

FAHRAEUS	NULL
R	NULL
,	NULL
RYMO	NULL
L	NULL
,	NULL
RHIM	NULL
JS	NULL
AND	NULL
KLEIN	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Morphological	NULL
transformation	NULL
of	NULL
human	NULL
keratinocytes	NULL
expressing	NULL
the	NULL
LMP	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Nature	NULL
,	NULL
345	NULL
,	NULL
447-449	NULL
.	NULL

GILLIGAN	NULL
K	NULL
,	NULL
SATO	NULL
H	NULL
,	NULL
RAJADURAI	NULL
P	NULL
,	NULL
BUSSON	NULL
P	NULL
,	NULL
YOUNG	NULL
L	NULL
,	NULL
RICKINSON	NULL
A	NULL
,	NULL
TURSZ	NULL
T	NULL
AND	NULL
RAAB-TRAUB	NULL
N.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Novel	NULL
transcription	NULL
from	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
terminal	NULL
EcoRI	NULL
fragment	NULL
,	NULL
DIJhet	NULL
,	NULL
in	NULL
a	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
4948-4956.	NULL
shown	NULL
to	NULL
block	NULL
calcium	NULL
mobilisation	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
thereby	NULL
suppressing	NULL
EBV	NULL
replication	NULL
(	NULL
Miller	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
is	NULL
unknown	NULL
whether	NULL
the	NULL
finding	NULL
can	NULL
be	NULL
extended	NULL
to	NULL
epithelial	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
at	NULL
least	NULL
in	NULL
certain	NULL
EBV-positive	NULL
gastric	NULL
carcinomas	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
tumour	NULL
cells	NULL
entering	NULL
the	NULL
lytic	NULL
cycle	NULL
may	NULL
be	NULL
associated	NULL
with	NULL
LMP2A	NULL
expression	NULL
.	NULL

It	NULL
was	NULL
inferred	NULL
from	NULL
our	NULL
series	NULL
of	NULL
data	NULL
that	NULL
,	NULL
unlike	NULL
in	NULL
NPC	NULL
or	NULL
OHL	NULL
cells	NULL
,	NULL
virus	NULL
replication	NULL
was	NULL
uncommon	NULL
or	NULL
abortive	NULL
in	NULL
gastric	NULL
carcinoma	NULL
,	NULL
and	NULL
that	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
tumour	NULL
cells	NULL
carried	NULL
EBV	NULL
in	NULL
a	NULL
tightly	NULL
latent	NULL
fashion	NULL
.	NULL

The	NULL
strict	NULL
localisation	NULL
of	NULL
EBV	NULL
genomes	NULL
and	NULL
viral	NULL
gene	NULL
expression	NULL
only	NULL
in	NULL
tumour	NULL
cells	NULL
and	NULL
their	NULL
monoclonality	NULL
(	NULL
Oda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Imai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
strongly	NULL
suggest	NULL
that	NULL
EBV	NULL
may	NULL
be	NULL
indeed	NULL
involved	NULL
,	NULL
not	NULL
a	NULL
passenger	NULL
,	NULL
in	NULL
the	NULL
development	NULL
of	NULL
virus-positive	NULL
gastric	NULL
carcinoma	NULL
,	NULL
although	NULL
several	NULL
questions	NULL
remain	NULL
to	NULL
be	NULL
resolved	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
understand	NULL
more	NULL
direct	NULL
oncogenic	NULL
activities	NULL
of	NULL
EBV	NULL
on	NULL
normal	NULL
gastric	NULL
mucosal	NULL
epithelia	NULL
and	NULL
a	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
enhancing	NULL
them	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Mr	NULL
Hideki	NULL
Nakamura	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
and	NULL
Mr	NULL
M	NULL
Kim	NULL
Barrymore	NULL
for	NULL
help	NULL
with	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
scientific	NULL
research	NULL
grant	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sports	NULL
and	NULL
Culture	NULL
,	NULL
a	NULL
grant-in-aid	NULL
for	NULL
the	NULL
10	NULL
year	NULL
strategy	NULL
for	NULL
cancer	NULL
control	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
,	NULL
Japan	NULL
,	NULL
and	NULL
a	NULL
research	NULL
grant	NULL
from	NULL
the	NULL
Suhara	NULL
Memorial	NULL
Foundation	NULL
.	NULL

GREENSPAN	NULL
JS	NULL
,	NULL
GREENSPAN	NULL
D	NULL
,	NULL
LENNETTE	NULL
ET	NULL
,	NULL
ABRAMS	NULL
DI	NULL
,	NULL
CONANT	NULL
MA	NULL
,	NULL
PETERSEN	NULL
V	NULL
AND	NULL
FREESE	NULL
UK	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
within	NULL
the	NULL
epithelial	NULL
cells	NULL
of	NULL
oral	NULL
'hairy	NULL
'	NULL
leukoplakia	NULL
,	NULL
an	NULL
AIDS-associated	NULL
lesion	NULL
.	NULL

N.	NULL
Eng/	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
313	NULL
,	NULL
1564-1571	NULL
.	NULL

HARABUCHI	NULL
Y	NULL
,	NULL
YAMANAKA	NULL
N	NULL
,	NULL
KATAURA	NULL
A	NULL
,	NULL
IMAI	NULL
S	NULL
,	NULL
KINOSHITA	NULL
T	NULL
,	NULL
MIZUNO	NULL
F	NULL
AND	NULL
OSATO	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
in	NULL
nasal	NULL
T-cell	NULL
lymphomas	NULL
in	NULL
patients	NULL
with	NULL
lethal	NULL
midline	NULL
granuloma	NULL
.	NULL

Lancet	NULL
,	NULL
335	NULL
,	NULL
128-130	NULL
.	NULL

HERBST	NULL
H	NULL
,	NULL
DALLENBACH	NULL
F	NULL
,	NULL
HUMMEL	NULL
M	NULL
,	NULL
NIEDOBITEK	NULL
G	NULL
,	NULL
PILERI	NULL
$	NULL
,	NULL
MULLER	NULL
LN	NULL
AND	NULL
STEIN	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
expression	NULL
in	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
4766-4770	NULL
.	NULL

IMAI	NULL
S	NULL
,	NULL
KOIZUMI	NULL
$	NULL
,	NULL
SUGIURA	NULL
M	NULL
,	NULL
TOKUNAGA	NULL
M	NULL
,	NULL
UEMURA	NULL
Y	NULL
,	NULL
YAMAMOTO	NULL
N	NULL
,	NULL
TANAKA	NULL
S	NULL
,	NULL
SATO	NULL
E	NULL
AND	NULL
OSATO	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Gastric	NULL
carcinoma	NULL
:	NULL
monoclonal	NULL
epithelial	NULL
malignant	NULL
cells	NULL
expressing	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
infection	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
9131-9135	NULL
.	NULL

KERR	NULL
BM	NULL
,	NULL
LEAR	NULL
AL	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
CROOM	NULL
CD	NULL
,	NULL
YOUNG	NULL
LS	NULL
,	NULL
ROOKES	NULL
SM	NULL
,	NULL
GALLIMORE	NULL
PH	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Three	NULL
transcriptionally	NULL
distinct	NULL
forms	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latency	NULL
in	NULL
somatic	NULL
cell	NULL
hybrids	NULL
:	NULL
cell	NULL
phenotype	NULL
dependence	NULL
of	NULL
virus	NULL
promoter	NULL
usage	NULL
.	NULL

Virology	NULL
,	NULL
187	NULL
,	NULL
189-201	NULL
.	NULL

KHANNA	NULL
R	NULL
,	NULL
BURROWS	NULL
SR	NULL
,	NULL
KURILLA	NULL
MG	NULL
,	NULL
JACOB	NULL
CA	NULL
,	NULL
MISKO	NULL
IS	NULL
,	NULL
SCULLEY	NULL
TB	NULL
,	NULL
KIEFF	NULL
E	NULL
AND	NULL
MOSS	NULL
DJ	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Localization	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
cytotoxic	NULL
T	NULL
cell	NULL
epitopes	NULL
using	NULL
recombinant	NULL
vaccinia	NULL
:	NULL
implications	NULL
for	NULL
vaccine	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
176	NULL
,	NULL
169-176	NULL
.	NULL

KLEIN	NULL
G	NULL
,	NULL
LINDAHL	NULL
T	NULL
,	NULL
JONDAL	NULL
M	NULL
,	NULL
LEIBOLD	NULL
W	NULL
,	NULL
MENEZES	NULL
J	NULL
,	NULL
NILSSON	NULL
K	NULL
AND	NULL
SUNDSTROM	NULL
C.	NULL
(	NULL
1974	NULL
)	NULL
.	NULL

Continuous	NULL
lymphoid	NULL
cell	NULL
lines	NULL
with	NULL
characteristics	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
bone	NULL
marrow-derived	NULL
)	NULL
,	NULL
lacking	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
and	NULL
derived	NULL
from	NULL
three	NULL
human	NULL
lymphomas	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
71	NULL
,	NULL
3283-3286	NULL
.	NULL

KORBJUHN	NULL
P	NULL
,	NULL
ANAGNOSTOPOULOS	NULL
I	NULL
,	NULL
HUMMEL	NULL
M	NULL
,	NULL
TIEMANN	NULL
M	NULL
,	NULL
DALLENBACH	NULL
F	NULL
,	NULL
PARWARESCH	NULL
MR	NULL
AND	NULL
STEIN	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Frequent	NULL
latent	NULL
Epstein	NULL
-	NULL
Barr	NULL
virus	NULL
infection	NULL
of	NULL
neoplastic	NULL
T	NULL
cells	NULL
and	NULL
bystander	NULL
B	NULL
cells	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus-negative	NULL
European	NULL
peripheral	NULL
pleomorphic	NULL
T-cell	NULL
lymphomas	NULL
.	NULL

Blood	NULL
,	NULL
82	NULL
,	NULL
217-223	NULL
.	NULL

LEAR	NULL
AL	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
KURILLA	NULL
MG	NULL
,	NULL
LEE	NULL
S	NULL
,	NULL
HENDERSON	NULL
S	NULL
,	NULL
KIEFF	NULL
E	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
nuclear	NULL
antigen	NULL
1	NULL
BamHI	NULL
F	NULL
promoter	NULL
is	NULL
activated	NULL
on	NULL
entry	NULL
of	NULL
EBV-transformed	NULL
B	NULL
cells	NULL
into	NULL
the	NULL
lytic	NULL
cycle	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
7461	NULL
7468	NULL
.	NULL

LEVITSKAYA	NULL
J	NULL
,	NULL
CORAM	NULL
M	NULL
,	NULL
LEVITSKY	NULL
V	NULL
,	NULL
IMREH	NULL
$	NULL
,	NULL
STEIGERWALD-MULLEN	NULL
PM	NULL
,	NULL
KLEIN	NULL
G	NULL
,	NULL
KURILLA	NULL
MG	NULL
AND	NULL
MASUCCI	NULL
MG.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
antigen	NULL
processing	NULL
by	NULL
the	NULL
internal	NULL
repeat	NULL
region	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen-1	NULL
.	NULL

Nature	NULL
,	NULL
375	NULL
,	NULL
685-688	NULL
.	NULL

LEYVRAZ	NULL
S	NULL
$	NULL
,	NULL
HENLE	NULL
W	NULL
,	NULL
CHAHINIAN	NULL
AP	NULL
,	NULL
PERLMANN	NULL
C	NULL
,	NULL
KLEIN	NULL
G	NULL
,	NULL
GORDON	NULL
RE	NULL
,	NULL
ROSENBLUM	NULL
M	NULL
AND	NULL
HOLLAND	NULL
JF	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Association	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
with	NULL
thymic	NULL
carcinoma	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
312	NULL
,	NULL
1296-1299	NULL
.	NULL

LL	NULL
QX	NULL
,	NULL
YOUNG	NULL
LS	NULL
,	NULL
NIEDOBITEK	NULL
G	NULL
,	NULL
DAWSON	NULL
CW	NULL
,	NULL
BIRKENBACH	NULL
M	NULL
,	NULL
WANG	NULL
F	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Epstein-Bar	NULL
virus	NULL
infection	NULL
and	NULL
replication	NULL
in	NULL
a	NULL
human	NULL
epithelial	NULL
cell	NULL
system	NULL
.	NULL

Nature	NULL
,	NULL
356	NULL
,	NULL
347-350	NULL
.	NULL

LIEBOWITZ	NULL
D	NULL
AND	NULL
KIEFF	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
.	NULL

In	NULL
The	NULL
Human	NULL
Herpesviruses	NULL
.	NULL

Roizman	NULL
B	NULL
,	NULL
Whitley	NULL
RJ	NULL
and	NULL
Lopez	NULL
C.	NULL
(	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

107-172	NULL
.	NULL

Raven	NULL
Press	NULL
:	NULL
New	NULL
York	NULL
.	NULL

MILLER	NULL
G	NULL
AND	NULL
LIPMAN	NULL
M.	NULL
(	NULL
1973	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
infectious	NULL
Epstein	NULL
Barr	NULL
virus	NULL
by	NULL
transformed	NULL
marmoset	NULL
leukocytes	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
70	NULL
,	NULL
190-194	NULL
.	NULL

MILLER	NULL
CL	NULL
,	NULL
LONGNECKER	NULL
R	NULL
AND	NULL
KIEFF	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
2A	NULL
blocks	NULL
calcium	NULL
mobilization	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
3087-3094	NULL
.	NULL

MILLER	NULL
CL	NULL
,	NULL
LEE	NULL
JH	NULL
,	NULL
KIEFF	NULL
E	NULL
AND	NULL
LONGNECKER	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

An	NULL
integral	NULL
membrane	NULL
protein	NULL
(	NULL
LMP2	NULL
)	NULL
blocks	NULL
reactivation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
from	NULL
latency	NULL
following	NULL
surface	NULL
immunoglobulin	NULL
crosslinking	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
,	NULL
772-776	NULL
.	NULL

MILLER	NULL
WE	NULL
,	NULL
EARP	NULL
HS	NULL
AND	NULL
RAAB-TRAUB	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
Epstein	NULL
Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
4390-4398	NULL
.	NULL

MOSS	NULL
DJ	NULL
,	NULL
CHAN	NULL
SH	NULL
,	NULL
BURROWS	NULL
SR	NULL
,	NULL
CHEW	NULL
TS	NULL
,	NULL
KANE	NULL
RG	NULL
,	NULL
STAPLES	NULL
JA	NULL
AND	NULL
KUNARATNAM	NULL
N.	NULL
(	NULL
1983	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
specific	NULL
T-cell	NULL
response	NULL
in	NULL
nasopharyngeal	NULL
carcinoma	NULL
patients	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
32	NULL
,	NULL
301-305	NULL
.	NULL

MURRAY	NULL
RJ	NULL
,	NULL
KURILLA	NULL
MG	NULL
,	NULL
BROOKS	NULL
JM	NULL
,	NULL
THOMAS	NULL
WA	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
KIEFF	NULL
E	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
target	NULL
antigens	NULL
for	NULL
the	NULL
human	NULL
cytotoxic	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
:	NULL
implications	NULL
for	NULL
the	NULL
immune	NULL
control	NULL
of	NULL
EBV-positive	NULL
malignancies	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
176	NULL
,	NULL
157-168	NULL
.	NULL

NIEDOBITEK	NULL
G	NULL
,	NULL
HERBST	NULL
H	NULL
,	NULL
YOUNG	NULL
LS	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
DIENEMANN	NULL
D	NULL
,	NULL
GERMER	NULL
C	NULL
AND	NULL
STEIN	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
carcinomas	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
in	NULL
an	NULL
undifferentiated	NULL
gastric	NULL
carcinoma	NULL
.	NULL

Diag	NULL
.	NULL

Mol	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
1	NULL
,	NULL
103-108	NULL
.	NULL

NONKWELO	NULL
C	NULL
,	NULL
SKINNER	NULL
J	NULL
,	NULL
BELL	NULL
A	NULL
,	NULL
RICKINSON	NULL
A	NULL
AND	NULL
SAMPLE	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Transcription	NULL
start	NULL
sites	NULL
downstream	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
Fp	NULL
promoter	NULL
in	NULL
early-passage	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
define	NULL
a	NULL
fourth	NULL
promoter	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
EBV	NULL
EBNA-1	NULL
protein	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
70	NULL
,	NULL
623-627	NULL
.	NULL

ODA	NULL
K	NULL
,	NULL
TAMARU	NULL
J	NULL
,	NULL
TAKENOUCHI	NULL
T	NULL
,	NULL
MIKATA	NULL
A	NULL
,	NULL
NUNOMURA	NULL
M	NULL
,	NULL
SAITOH	NULL
N	NULL
,	NULL
SARASHINA	NULL
H	NULL
AND	NULL
NAKAJIMA	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Association	NULL
of	NULL
Epstein	NULL
-	NULL
Barr	NULL
virus	NULL
with	NULL
gastric	NULL
carcinoma	NULL
with	NULL
lymphoid	NULL
stroma	NULL
.	NULL

4m	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
143	NULL
,	NULL
1063-1071	NULL
.	NULL

PALLESEN	NULL
G	NULL
,	NULL
HAMILTON	NULL
DS	NULL
,	NULL
ROWE	NULL
M	NULL
AND	NULL
YOUNG	NULL
LS	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
products	NULL
in	NULL
tumour	NULL
cells	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Lancet	NULL
,	NULL
337	NULL
,	NULL
320-322	NULL
.	NULL

PATTON	NULL
DF	NULL
,	NULL
RIBEIRO	NULL
RC	NULL
,	NULL
JENKINS	NULL
JJ	NULL
AND	NULL
SIXBEY	NULL
JW	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Thymic	NULL
carcinoma	NULL
with	NULL
a	NULL
defective	NULL
Epstein-Barr	NULL
virus	NULL
encoding	NULL
the	NULL
BZLFI	NULL
trans-activator	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

,	NULL
170	NULL
,	NULL
7-12	NULL
.	NULL

QU	NULL
L	NULL
AND	NULL
ROWE	NULL
DT	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
uncultured	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
3715-3724	NULL
.	NULL

ROGERS	NULL
RP	NULL
,	NULL
WOISETSCHLAEGER	NULL
M	NULL
AND	NULL
SPECK	NULL
SH	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Alternative	NULL
splicing	NULL
dictates	NULL
translational	NULL
start	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
transcripts	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
2273-2277	NULL
.	NULL

EBV	NULL
gene	NULL
expression	NULL
in	NULL
gastric	NULL
carcinoma	NULL
M	NULL
Sugiura	NULL
et	NULL
al	NULL
ROONEY	NULL
CM	NULL
,	NULL
RICKINSON	NULL
AB	NULL
,	NULL
MOSS	NULL
DJ	NULL
,	NULL
LENOIR	NULL
GM	NULL
AND	NULL
EPSTEIN	NULL
MA	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Cell-mediated	NULL
immunosurveillance	NULL
mechanisms	NULL
and	NULL
pathogenesis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

IARC	NULL
Scient	NULL
.	NULL

Publ	NULL
.	NULL

,	NULL
60	NULL
,	NULL
249-264	NULL
.	NULL

ROWE	NULL
M	NULL
,	NULL
ROWE	NULL
DT	NULL
,	NULL
GREGORY	NULL
CD	NULL
,	NULL
YOUNG	NULL
LS	NULL
,	NULL
FARRELL	NULL
PJ	NULL
,	NULL
RUPANI	NULL
H	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Differences	NULL
in	NULL
B	NULL
cell	NULL
growth	NULL
phenotype	NULL
reflect	NULL
novel	NULL
patterns	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
6	NULL
,	NULL
2743-2751	NULL
.	NULL

SAMPLE	NULL
J	NULL
,	NULL
BROOKS	NULL
L	NULL
,	NULL
SAMPLE	NULL
C	NULL
,	NULL
YOUNG	NULL
L	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
GREGORY	NULL
C	NULL
,	NULL
RICKINSON	NULL
A	NULL
AND	NULL
KIEFF	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Restricted	NULL
Epstein-Barr	NULL
virus	NULL
protein	NULL
expression	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
is	NULL
due	NULL
to	NULL
a	NULL
different	NULL
Epstein-Barr	NULL
nuclear	NULL
antigen	NULL
1	NULL
transcriptional	NULL
initiation	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
6343-6347	NULL
.	NULL

SCHAEFER	NULL
BC	NULL
,	NULL
WOISETSCHLAEGER	NULL
M	NULL
,	NULL
STROMINGER	NULL
JL	NULL
AND	NULL
SPECK	NULL
SH	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Exclusive	NULL
expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
1	NULL
in	NULL
Burkitt	NULL
lymphoma	NULL
arises	NULL
from	NULL
a	NULL
third	NULL
promoter	NULL
,	NULL
distinct	NULL
from	NULL
the	NULL
promoters	NULL
used	NULL
in	NULL
latently	NULL
infected	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
6550-6554	NULL
.	NULL

SCHAEFER	NULL
BC	NULL
,	NULL
STROMINGER	NULL
JL	NULL
AND	NULL
SPECK	NULL
SH	NULL
.	NULL

(	NULL
19954	NULL
)	NULL
.	NULL

Redefining	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigen	NULL
EBNA-1	NULL
gene	NULL
promoter	NULL
and	NULL
transcription	NULL
initiation	NULL
site	NULL
in	NULL
group	NULL
I	NULL
Burkitt	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
10565-10569	NULL
.	NULL

SCHAEFER	NULL
BC	NULL
,	NULL
STROMINGER	NULL
JL	NULL
AND	NULL
SPECK	NULL
SH	NULL
.	NULL

(	NULL
19956	NULL
)	NULL
.	NULL

The	NULL
Epstein	NULL
-	NULL
Barr	NULL
virus	NULL
BamHI	NULL
F	NULL
promoter	NULL
is	NULL
an	NULL
early	NULL
lytic	NULL
promoter	NULL
:	NULL
lack	NULL
of	NULL
correlation	NULL
with	NULL
EBNA	NULL
1	NULL
gene	NULL
transcription	NULL
in	NULL
group	NULL
1	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
.	NULL

Viro/	NULL
.	NULL

,	NULL
69	NULL
,	NULL
5039-5047	NULL
.	NULL

SHIBATA	NULL
D	NULL
,	NULL
TOKUNAGA	NULL
M	NULL
,	NULL
UEMURA	NULL
Y	NULL
,	NULL
SATO	NULL
E	NULL
,	NULL
TANAKA	NULL
S	NULL
AND	NULL
WEISS	NULL
LM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Association	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
with	NULL
undifferentiated	NULL
gastric	NULL
carcinomas	NULL
with	NULL
intense	NULL
lymphoid	NULL
infiltration	NULL
.	NULL

Lymphoepithelioma-like	NULL
carcinoma	NULL
.	NULL

Am	NULL
.	NULL

J	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
139	NULL
,	NULL
469-474	NULL
.	NULL

SHIMIZU	NULL
N	NULL
,	NULL
TANABE-TOCHIKURA	NULL
A	NULL
,	NULL
KUROIWA	NULL
Y	NULL
AND	NULL
TAKADA	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-negative	NULL
cell	NULL
clones	NULL
from	NULL
the	NULL
EBV-positive	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
line	NULL
Akata	NULL
:	NULL
malignant	NULL
phenotypes	NULL
of	NULL
BL	NULL
cells	NULL
are	NULL
dependent	NULL
on	NULL
EBV	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
68	NULL
,	NULL
6069-6073	NULL
.	NULL

SIXBEY	NULL
JW	NULL
AND	NULL
YAO	NULL
QY	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Immunoglobulin	NULL
A-induced	NULL
shift	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
tissue	NULL
tropism	NULL
.	NULL

Science	NULL
,	NULL
255	NULL
,	NULL
1578-1580	NULL
.	NULL

SU	NULL
IJ	NULL
,	NULL
HSIEH	NULL
HC	NULL
,	NULL
LIN	NULL
KH	NULL
,	NULL
UEN	NULL
WC	NULL
,	NULL
KAO	NULL
CL	NULL
,	NULL
CHEN	NULL
CJ	NULL
,	NULL
CHENG	NULL
AL	NULL
,	NULL
KADIN	NULL
ME	NULL
AND	NULL
CHEN	NULL
JY	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Aggressive	NULL
peripheral	NULL
T-cell	NULL
lymphomas	NULL
containing	NULL
Epstein-Barr	NULL
viral	NULL
DNA	NULL
:	NULL
a	NULL
clinicopatho-logic	NULL
and	NULL
molecular	NULL
analysis	NULL
.	NULL

Blood	NULL
,	NULL
77	NULL
,	NULL
799-808	NULL
.	NULL

TAKADA	NULL
K	NULL
AND	NULL
ONO	NULL
Y	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Synchronous	NULL
and	NULL
sequential	NULL
activation	NULL
of	NULL
latently	NULL
infected	NULL
Epstein-Barr	NULL
virus	NULL
genomes	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
63	NULL
,	NULL
445-449	NULL
.	NULL

TIERNEY	NULL
RJ	NULL
,	NULL
STEVEN	NULL
N	NULL
,	NULL
YOUNG	NULL
LS	NULL
AND	NULL
RICKINSON	NULL
AB	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Epstein	NULL
--	NULL
Barr	NULL
virus	NULL
latency	NULL
in	NULL
blood	NULL
mononuclear	NULL
cells	NULL
:	NULL
analysis	NULL
of	NULL
viral	NULL
gene	NULL
transcription	NULL
during	NULL
primary	NULL
infection	NULL
and	NULL
in	NULL
the	NULL
carrier	NULL
state	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
68	NULL
,	NULL
7374-7385	NULL
.	NULL

WANG	NULL
D	NULL
,	NULL
LIEBOWITZ	NULL
D	NULL
AND	NULL
KIEFF	NULL
E.	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
43	NULL
,	NULL
831-840	NULL
.	NULL

YOUNG	NULL
L	NULL
,	NULL
ALFIERI	NULL
C	NULL
,	NULL
HENNESSY	NULL
K	NULL
,	NULL
EVANS	NULL
H	NULL
,	NULL
O'HARA	NULL
C	NULL
,	NULL
ANDERSON	NULL
KC	NULL
,	NULL
RITZ	NULL
J	NULL
,	NULL
SHAPIRO	NULL
RS	NULL
,	NULL
RICKINSON	NULL
A	NULL
,	NULL
KIEFF	NULL
E	NULL
AND	NULL
COHEN	NULL
JI	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
transformation-associated	NULL
genes	NULL
in	NULL
tissues	NULL
of	NULL
patients	NULL
with	NULL
EBV	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
321	NULL
,	NULL
1080-1085	NULL
.	NULL

YOUNG	NULL
LS	NULL
,	NULL
LAU	NULL
R	NULL
,	NULL
ROWE	NULL
M	NULL
,	NULL
NIEDOBITEK	NULL
G	NULL
,	NULL
PACKHAM	NULL
G	NULL
,	NULL
SHANAHAN	NULL
F	NULL
,	NULL
ROWE	NULL
DT	NULL
,	NULL
GREENSPAN	NULL
D	NULL
,	NULL
GREENSPAN	NULL
JS	NULL
,	NULL
RICKINSON	NULL
AB	NULL
AND	NULL
FARREL	NULL
PJ	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Differentiation-associated	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
BZLFI	NULL
transactivator	NULL
protein	NULL
in	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
2868-2874	NULL
.	NULL

631	NULL

